Yang et al. revealed that STC2 controls HNSCC metastasis via the PI3K/AKT/Snail signaling pathway and that targeted therapy against STC2 may be a novel strategy to effectively treat patients with metastatic HNSCC47. The gene discussed is AKT1; the disease is head and neck squamous cell carcinoma.